Clinical Trial launches to develop breath test for multiple cancers
Owlstone Medical (or the “Company”), a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Cancer Research UK, today announces the clinical launch of the PAN Cancer trial for Early Detection of Cancer in Breath, with the first patients now being recruited for the 1,500 patient study.
Source: news-medical.net